After pre-treatment with 5 μM vemurafenib, we observed a significant reduction in cell viability when combined with CBD 6 μM and THC 15 μM (Figure 5E), suggesting that cannabinoids might be able to resensitize some melanoma cells for BRAF inhibitor therapy. Here, BRAF is linked to melanoma.